Jun Won Chwa

Title: Jun Won Chwa and a Broader Pneumococcal Vaccine Approach.

Introduction

Jun Won Chwa is an inventor associated with Celltrion Inc. in Incheon, South Korea. His listed patent work concerns a multivalent immunogenic composition designed to protect against a broader range of pneumococcal serotypes.

Latest Patents

Chwa is credited with 1 patent: “Immunogenic Composition Comprising Multivalent Polysaccharide-Protein Conjugates.” The invention describes a composition containing pneumococcal capsular polysaccharides from multiple serotypes, each conjugated to a carrier protein. It combines serotypes included in the conventional Prevenar 13 formulation with additional serotypes, including 10A, 11A, 12F, 15B, 22F, 23A, and 35B. The patent describes the composition as intended to induce immune responses across a wider variety of serotypes, with the potential for broader coverage in Asia as well as Europe and North America. It is presented as a possible approach to preventing pneumococcal disease in infants, children, and adults.

Career Highlights

The available information connects Chwa’s patent activity with Celltrion Inc. and highlights his contribution to vaccine-related innovation. His listed invention focuses on expanding the range of pneumococcal serotypes addressed by a multivalent vaccine composition.

Collaborations

Chwa’s listed coworkers include Kyung Min Jo and Pan Kyeom Kim. The provided information does not specify their individual roles in the patent or their broader professional relationship with Chwa.

Conclusion

Jun Won Chwa’s listed patent centers on a multivalent pneumococcal vaccine composition intended to broaden serotype coverage, reflecting an innovation aimed at supporting protection against pneumococcal disease across diverse populations.